A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT02080871
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT02080871
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT02080871. Allocation not applicable; no masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2016-05 (actual). Results posted on 2018-07-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
- Acronym
- VBXFLEX
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Stenting of the Common and/or External Iliac Arteries
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct02080871- Content hash
60c543cc47334bd3d79af68bd803f87e15314158490a4f67ee8d7a416a041bb2